MedPath
NMPA Approval

Cefoperazone Sodium and Tazobactam Sodium for Injection(4:1)

国药准字H20193193

July 4, 2019

Drug Information

注射用头孢哌酮钠他唑巴坦钠(4:1)

注射剂

1.0g(C25H27N9O8S2 0.8g与C10H12N4O5S 0.2g)。

化学药品

July 4, 2019

Company Information

Applicant Company

江苏省苏州吴中经济开发区民丰路268号

Manufacturing Company

苏州东瑞制药有限公司;华北制药河北华民药业有限责任公司

江苏省苏州吴中经济开发区天灵路22号;石家庄经济技术开发区海南路98号(103车间B线和101车间1A1线)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用头孢哌酮钠他唑巴坦钠(4:1) - NMPA 批准文号 | MedPath